Tenax Therapeutics Provides Update on TNX-102, TNX-103 and TNX-201 Clinical Programs

Go back to Tenax Therapeutics Provides Update on TNX-102, TNX-103 and TNX-201 Clinical Programs
(NASDAQ: TENX) Delayed: 2.13 -0.06 (2.74%)
Previous Close $2.19    52 Week High $3.40 
Open $2.16    52 Week Low $1.34 
Day High $2.29    P/E N/A 
Day Low $2.12    EPS $0.00 
Volume 2,801,305